Clinical Scorecard: CDC Reports Record High U.S. Life Expectancy Reaches 79 Years in 2024
At a Glance
Category
Detail
Condition
Life expectancy and mortality trends in the U.S.
Key Mechanisms
Decline in death rates from Covid-19, heart disease, cancer, drug overdoses, and other leading causes
Target Population
U.S. residents across all racial and ethnic groups, men and women
Care Setting
Public health and clinical settings addressing chronic disease management and injury prevention
Key Highlights
U.S. life expectancy rose to 79 years in 2024, the highest recorded in American history.
Death rates declined across all major causes including heart disease, drug overdoses, and Covid-19.
Preliminary 2025 data suggest continued improvement in mortality and life expectancy.
Guideline-Based Recommendations
Diagnosis
Monitor mortality trends through national health statistics to identify leading causes of death.
Assess individual risk factors for heart disease, substance use, and injury.
Management
Implement evidence-based treatments for heart disease including weight management and medical therapies.
Continue public health interventions to reduce drug overdoses and unintentional injuries.
Maintain Covid-19 prevention and treatment strategies despite reduced mortality.
Monitoring & Follow-up
Track death rates by cause, race, ethnicity, and sex to identify disparities and progress.
Use preliminary mortality data to anticipate trends and allocate resources accordingly.
Risks
Persistent high rates of heart disease remain the leading cause of death.
Suicide remains a top 10 cause of death despite recent declines.
U.S. life expectancy still lags behind many other countries, indicating ongoing health challenges.
Patient & Prescribing Data
U.S. population affected by chronic diseases and injury-related mortality
Advances in medical treatments and weight management contribute to declining heart disease mortality; ongoing efforts needed to address substance use and mental health.
Clinical Best Practices
Prioritize comprehensive cardiovascular risk reduction including lifestyle and pharmacologic interventions.
Enhance screening and intervention programs for substance use disorders to reduce overdose deaths.
Incorporate mental health support and suicide prevention strategies into routine care.
Utilize up-to-date mortality data to guide public health policies and clinical priorities.
Damon B. Dixon, MD, at Phoenix Children’s Cardiology, is the author to this EndoText chapter. Dr. Dixon brings nationally recognized expertise in pediatric cardiovascular risk assessment and non?invasive vascular imaging.
